Trial | NCT00150696  Report issue

Title

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.
Risedronate for Prevention of Osteoporosis After Spinal Cord Injury

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    38
The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.
Study Started
Feb 29
2000
Study Completion
Nov 30
2005
Last Update
Nov 21
2007
Estimate

Drug Risedronate

Criteria 

Inclusion Criteria:

Traumatic spinal cord injury less than 100 days.
Must be able to swallow tablets and sit upright.

Exclusion Criteria:

Bilateral knee flexion contractures.
Pregnant, lactating or post-menopausal females.
Paget's disease, osteomalacia, steroid induced bone loss, untreated thyroid disease, iritis, uveitis, pancreatitis, gastritis, peptic ulcer or cholecystitis.
Treatment in the last year with calcitonin, fluoride or anabolic steroid.
Concurrent treatment with prednisone.
No Results Posted